Naringenin protects AlCl(3)/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress

Currently prescribed medications for the treatment of Alzheimer’s disease (AD) that are based on acetylcholinesterase inhibition only offer symptomatic relief but do not provide protection against neurodegeneration. There appear to be an intense need for the development of therapeutic strategies tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Haider, Saida, Liaquat, Laraib, Ahmad, Saara, Batool, Zehra, Siddiqui, Rafat Ali, Tabassum, Saiqa, Shahzad, Sidrah, Rafiq, Sahar, Naz, Narjis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964982/
https://www.ncbi.nlm.nih.gov/pubmed/31945778
http://dx.doi.org/10.1371/journal.pone.0227631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964982/
https://www.ncbi.nlm.nih.gov/pubmed/31945778
http://dx.doi.org/10.1371/journal.pone.0227631

Ejemplares similares